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The assembly of herpesvirus remains incompletely defined due to the structural complexity of these viruses.
Although the assembly of the capsid of these large DNA viruses is well studied and reasonably well conserved
for all members of this diverse family of viruses, the cytoplasmic processes of tegumentation and envelopment
are not well understood. The virion of the largest human herpesvirus, human cytomegalovirus (HCMV),
contains over 70 virus-encoded proteins that are incorporated during a nuclear and cytoplasmic phase of
assembly. Envelopment of this virus requires the function of at least one tegument protein, pp28, the product
of the UL99 open reading frame. However, the role of pp28 in the envelopment of HCMV remains undefined.
We have generated a pp28 mutant virus that encodes only the first 50 amino acids (aa) of this 190-aa virion
protein. This virus is replication impaired and is defective in virus assembly. Characterization of both
intracellular and extracellular virions from cells infected with this viral mutant indicated that the decrease in
production of infectious virus was secondary to a defect in envelopment and the accumulation of tegumented,
noninfectious intracellular particles. Image analysis using fluorescence recovery after photobleaching indi-
cated that the pp28 mutant protein encoded by this virus failed to efficiently accumulate in the virus assembly
compartment (AC). Our results suggest that pp28 must accumulate in the AC for efficient envelopment of the
particle and provide evidence for a direct role of this tegument protein in the late stages of assembly, such as
envelopment.
Infection with human cytomegalovirus (HCMV) has been
associated with acute and chronic disease in both healthy and
immunocompromised populations (7, 21, 28). Although a con-
siderable body of knowledge about HCMV replication has
been gathered, particularly about the regulation of viral gene
expression and interactions with cellular transcription pro-
grams during infection, a similarly detailed description of the
assembly of HCMV has not been accomplished. Like more
well described alphaherpesviruses such as herpes simplex virus
(HSV) and pseudorabies virus (PRV), DNA replication, en-
capsidation, and capsid assembly take place in the nuclei of
infected cells (19). The processes of nuclear egress, cytoplas-
mic envelopment, and virion release from the infected cell
have not been completely defined for HSV or PRV, and these
processes remain even less well defined for HCMV because of
the increased structural complexity of this prototypic member
of the betaherpesvirus family (2, 11–13, 16, 18, 19, 30). More-
over, the infectious particle of HCMV contains proteins that
have no homologous proteins in HSV or PRV and, based on
the eclipse period in permissive cells, is assembled with signif-
icantly delayed kinetics compared to either HSV or PRV (8,
19). Additional findings highlight the potential differences in
the assembly pathways of HCMV and HSV or PRV, including
the presence of tegumented particles in the nuclei of HCMV-
infected cells (27). Furthermore, several tegument and enve-
lope proteins that have been shown to be dispensable for the
assembly of infectious HSV or PRV particles have homologous
proteins in HCMV that are essential for the assembly of in-
fectious virus (5, 15, 17, 18, 24, 26, 27). More recent studies
have also argued that HCMV could be enveloped in a different
cellular compartment than has been proposed for HSV or
PRV (10, 18). These observations have led investigators to
postulate that the cytoplasmic assembly of HCMV could share
some features of the pathways proposed for HSV but also
differs fundamentally in many aspects of virus assembly.
Several approaches for the study of HCMV have been re-
ported, but the most informative has been the characterization
of viral mutants that exhibit phenotypic defects in assembly.
Utilizing genetic systems introduced by Messerle and Koszi-
nowski, several laboratories have described the phenotypes of
viral mutants with defined mutations in single open reading
frames (ORFs) (4, 5, 24, 26). The deletion of essential enve-
lope glycoproteins such as glycoprotein B (gB), gH, or gM
resulted in the loss of virus infectivity (14, 17). Similarly, the
deletion of capsid proteins also prevented the recovery of in-
fectious virus (14). In contrast to these findings, viral mutants
with deletions of tegument proteins have exhibited more-vari-
able phenotypes in terms of virus replication (9, 32). One such
tegument protein that has been studied by several laboratories
is pp28, the product of the UL99 ORF. This protein has been
shown to be essential for the production of infectious virus,
and deletion of this ORF resulted in a viral mutant that could
not assemble enveloped particles (5, 15, 26). A more recent
report has described the intercellular spread of pp28-negative
virions, although the relevance of this finding to the in vivo
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behavior of HCMV is unclear at this time (25). pp28 is a true
late protein that is membrane linked by myristoylation and by
palmitoylation (W. J. Britt, unpublished data) and is localized
to the cytoplasmic compartment designated the virus assembly
compartment (AC) (22, 23). This compartment is thought to
be a modified compartment of the cellular secretory system
and distal to the trans-Golgi network (TGN), possibly a com-
partment derived from late endosomes (22, 24). Localization
of pp28 to the AC is required for virus assembly, and mutations
that impair its localization in this compartment also limit the
production of infectious virus (24). Two different studies have
shown that only the first 60 amino acids (aa) of this 190-aa
phosphoprotein are required for the generation of viruses that
exhibit a phenotype of wild-type virus replication (15, 24).
Furthermore, these same studies demonstrated that infectious
virus was not recovered following the deletion of a 16-aa clus-
ter of acidic amino acids between aa 44 and 59, suggesting that
this stretch of amino acids is essential for the assembly of
infectious virus (15, 24). The role of this acidic cluster in the
function of pp28 in the assembly of infectious HCMV is un-
known, although potential roles in the interactions with cellu-
lar adaptor proteins have been proposed (15). Regardless of
the contribution of this domain of pp28 to its function in virus
assembly, pp28 is an essential structural protein, and thus far,
available data point to its critical role in the envelopment of
the infectious particle.
To further define the role of pp28 in the assembly of
HCMV, we have characterized the phenotype of a replication-
impaired virus mutant generated by the insertion of a transla-
tional stop codon at nucleotide position 151, resulting in a virus
encoding only the first 50 aa of pp28. The phenotype of this
mutant virus, pp28STOP50, was compared to that of a previ-
ously described viral mutant (pp28STOP61) that has been
shown to exhibit a wild-type phenotype in terms of virus rep-
lication, localization of the pp28 mutant protein to the AC, and
assembly of infectious enveloped particles (24). The phenotype
of the pp28STOP50 viral mutant was particularly informative
because, although replication impaired, this mutant produced
infectious particles that could be characterized during assem-
bly without the necessity of complementation, such as the
expression of pp28 in trans. Our results indicated that cells
infected with the pp28STOP50 mutant virus assembled intra-
cellular particles that contained similar quantities of viral
DNA, the virus major capsid protein (MCP), and at least one
viral tegument protein, yet were significantly less infectious
than particles produced by cells infected with the pp28STOP61
virus. Additional studies, including electron microscopy (EM)
and quantitation of a major envelope glycoprotein, gB, in par-
ticles produced by the pp28STOP50 virus-infected cells, indi-
cated that the majority of intracellular particles produced by
this mutant virus were nonenveloped and, thus, presumably
noninfectious. The pp28 mutant protein encoded by this virus
appeared to contribute to this loss of envelopment by failing to
accumulate in the AC of infected cells, supporting the argu-
ment that the role of pp28 in envelopment is expressed after its
localization in the AC. Finally, our results also suggested that
the incorporation of a threshold amount of pp28 during as-
sembly is sufficient for the envelopment of an infectious par-
ticle and, in turn, for the release into the extracellular super-
natant.
MATERIALS AND METHODS
Cells and viruses. Human primary fibroblasts (HF) were prepared and main-
tained in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 5%
newborn calf serum and penicillin and streptomycin antibiotics as described
previously (24). Wild-type virus (strain AD169) was obtained by electroporation
of the infectious clone HB-5 maintained in Escherichia coli into HF. This bac-
terial artificial chromosome (BAC) was obtained from Martin Messerle and
Ulrich Koszinowski (University of Munich, Germany) and was used to generate
all recombinant viruses in this study (4). The recombinant viruses pp28STOP61
and pp28STOP50 have been described previously and were constructed by the
insertion of a translational stop codon at nucleotide positions 184 and 151,
respectively (24).
Virus infections, infectivity titrations, and real-time PCR assays. Monolayers
of HF in 35-mm dishes were infected with a designated multiplicity of infection
(MOI) for 1 h with gentle rocking, washed, and then incubated at 37°C and 5%
CO2. Contents of dishes were harvested daily and either separated into cells and
supernatant or frozen at 80°C until titrated for infectivity. Results are ex-
pressed as infectious units/ml. Titrations were carried out as described previously
(1). Briefly, 0.2 ml of 10-fold dilutions was seeded in replicates (2, 3) in the wells
of a 96-well flat-bottom plate containing HF monolayers. After a 1-h incubation,
the wells were washed and the plate was incubated for 16 h. The plate was then
washed with phosphate-buffered salt solution (PBS; pH 7.4) and then fixed in
absolute ethanol for 20 min. The plate was then washed, a monoclonal antibody
(MAb) reactive with the IE-1 protein was added, and reactivity was developed
with fluorescein isothiocyanate anti-mouse immunoglobulin G antibodies (1).
The number of fluorescent nuclei was counted, and results were expressed as
infectious units per ml of input virus. Quantitation of the viral genome copy
number was carried out using real-time PCR, as we have described previously,
using UL55 as the target template (24).
EM analysis. HF were infected with the wild-type, the pp28STOP61, or the
pp28STOP50 virus at an MOI of 0.1 and processed for EM on day 5 postinfec-
tion. Cells were collected from the culture plate in 1 ml of PBS and centrifuged
into pellets. The resulting pellets were then rinsed with 0.1 M PBS and fixed with
2.5% glutaraldehyde in PBS for 1 h at room temperature. After being rinsed in
0.1 M PBS three times, pellets were postfixed in 1% osmium tetroxide for 1 h at
4°C in the dark. These pellets were rinsed with 0.1 M PBS three times and with
water once more. The pellets were then dehydrated in a graded series of ethanol
solutions beginning with 25% and ending with 100% and embedded on a copper
grid. Approximately 90-nm sections of the pellets were stained with 1% uranyl
acetate and lead citrate and examined with a Hitachi 7000 series EM at an
acceleration voltage of 75 kV.
Gradient separation of extracellular and intracellular virions. Extracellular
and intracellular virions were purified by centrifugation through sorbitol gradi-
ents as previously described (6). Briefly, supernatant virus was isolated by initially
clarifying the supernatant by centrifugation at 3,000 g for 15 min. Virions were
pelleted by centrifugation of the clarified supernatant through a 20% sucrose
cushion at 25,000 rpm in an SW28 rotor for 1 h. The pellet was then resuspended
in 1 ml of Tris-buffered saline (pH 7.4) and applied to a preformed 20 to 70%
sorbitol gradient (10 ml) and centrifuged at 27,000 rpm in an SW41 rotor for 1 h
at 16°C. Intracellular particles were prepared from postnuclear supernatants of
the same cultures of virus-infected cells by passing cells repeatedly through a
25-gauge needle followed by clarification of the cell lysate at 6,000 rpm for 10
min. This material was loaded directly onto preformed 20 to 70% sorbitol
gradients and centrifuged as described above. The gradients were fractionated
into 1-ml fractions from the bottom by pumping mineral oil onto the top of the
gradient. The infectivity titers of the fractions were determined, and the fractions
were analyzed for viral DNA by real-time PCR. Subsequently, individual frac-
tions were analyzed for viral proteins by Western blotting as described below.
Antibodies and Western blotting. MAbs used in this study include anti-MCP
MAb 28-4, anti-pp28 MAb 41-18, anti-gB MAb 7-17, anti-gM MAb IMP, and
anti-pp65 MAb 28-19 (22). Samples were analyzed by Western blotting as de-
scribed in previous publications and developed using enhanced chemilumines-
cence (Pierce Biotechnology, Rockford, IL).
Imaging and FRAP analysis. Immunofluorescence assays of viral protein ex-
pression in virus-infected cells was carried out as previously described (24).
Fluorescence recovery after photobleaching (FRAP) analysis was performed at
day 6 postinfection in live HF in which enhanced green fluorescent protein
(EGFP)-tagged pp28 protein was expressed following electroporation of a plas-
mid encoding the first 35 aa, 50 aa, or 61 aa of pp28 or the full length of the pp28
molecule fused at the C terminus to EGFP. Electroporated HF were infected
with HCMV 48 h later at anMOI of 0.1. The infected HF were grown on a
13-mm glass coverslip at 37°C in DMEM containing 10% fetal calf serum. At day
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6 postinfection, the infected live HF on a coverslip were washed with 25 mM
HEPES-buffered phenol red-free DMEM, and each coverslip was mounted on a
slide. A drop of this HEPES-buffered medium was added directly to the well
created by a rubber gasket (Molecular Probes) on the slide. The coverslip with
live cells was sealed onto the slide. Photobleaching was performed on a confocal
laser scanning microscope (Leica SP2). Cells expressing EGFP fusion proteins in
moderate amounts, i.e., with a sufficiently high fluorescence above background
levels, were monitored using the 488 laser line of the argon laser at 25% power
and bleached at 100% laser power. For AC bleaching or cytoplasm (except
nucleus and AC) bleaching, the regions of interest were bleached with three
subsequent bleach frames. The images were taken at a rate of 5 frames at 20-s
intervals for prebleaching, 3 frames at 2.9-s intervals for bleaching, and 40 frames
at 30-s intervals for postbleaching. The recovered fluorescence intensity in the
region of interest was measured and normalized. The intensity in the prebleach-
ing image was set at 100%, and the first postbleaching image was set as time point
0. The average fluorescence intensity was plotted over time. The recovery curves
shown in Fig. 7 are the mean values and standard errors of the recovery curves
for at least five cells (or three cells for cytoplasm bleaching experiments) and are
representative of two independent experiments.
RESULTS
A replication-competent HCMV expressing only the first 50
aa of pp28 has delayed replication kinetics. Previous studies
from our laboratory and other laboratories have reported that
a stretch of acidic amino acids between aa 44 and 59 of pp28
was required for the function of pp28 in the assembly of in-
fectious virus (Fig. 1) (15, 24). In addition, the function of this
cluster of acidic amino acids was context dependent in that the
deletion of this cluster of acidic amino acids and the transplan-
tation to the C terminus of pp28 failed to restore the function
of the protein (24). To further define the function of this acidic
domain in pp28, we generated three recombinant viruses con-
taining translational stop codons at aa positions 44, 51, and 62
(Fig. 1). As reported previously, infectious virus could be re-
covered from the pp28STOP61 and the pp28STOP50 HCMV
BAC but not from the pp28STOP43 BAC (24). Although in-
fectious virus could be recovered from the pp28STOP50 BAC,
the replication kinetics of this recombinant virus was delayed
compared to those of both the wild-type virus and the
pp28STOP61 virus, a mutant virus that replicates with kinetics
similar to that of the wild-type parent virus (24). Comparison
of the replication kinetics of the pp28STOP50 and pp28STOP61
viruses at low MOIs revealed that the pp28STOP50 virus-infected
cells produced about 2 logs less virus than that produced by cells
infected with the pp28STOP61 virus (Fig. 2). Similar levels of viral
genome replication were observed in cells infected with the pp28
STOP50 and pp28STOP61 viruses, indicating that the decrease in
virus yield was not secondary to a defect in genome replication
(Fig. 2). At higher MOIs (3–5), the differences in virus yields
between the pp28STOP50 and the pp28STOP61 viruses re-
mained but were less apparent than those previously reported for
infections at low MOIs (24).
The defect in the replication of the pp28STOP50 virus is not
related to virus entry or spread. To further investigate the role
of pp28 in the replication and assembly of HCMV, we char-
acterized the replication phenotype of the pp28STOP50 virus.
Initially, we determined whether the pp28STOP50 virus had a
deficit in virus entry and/or spread within a monolayer of
permissive HF. An assay of virus entry revealed that the pp28
FIG. 1. Amino acid sequence of pp28 and diagrammatic representation of recombinant HCMV BACs constructed for the generation of mutant
viruses. (A) Amino acid sequence of pp28 with aa 44 to 61 shown in larger, underlined type. The 16-aa acidic cluster is contained within this
sequence. (B) The structure of the HCMV genome with the UL99 ORF (nucleotides [nt] 145310 to 145795) shown in greater detail. The two viral
mutants characterized in this report, the pp28STOP61 and pp28STOP50 mutants, have been previously described with the locations of the
translational stop codons indicated (24).
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STOP50 virus entered HF as efficiently as the wild-type and the
pp28STOP61 viruses, suggesting that the replication defect in
the pp28STOP50 virus was not secondary to a defect in the
incorporation of a protein(s) essential for virus attachment and
entry (Fig. 3). Furthermore, we also analyzed the capacity of
the pp28STOP50 virus to spread between cells in a monolayer
of HF maintained under an agarose overlay. This assay allowed
us to measure the expansion of an infectious center as a func-
tion of time and thus provided quantitation of the capacity of
these viruses to spread within a monolayer, independently of
extracellular virus yield. We found no differences in the rates
of spread of the pp28STOP50 and the wild-type viruses, again
suggesting that the defect in virus production associated with
the pp28STOP50 virus was not directly related to virus entry or
spread between cells (Fig. 4). Our previous findings indicated
that the pp28STOP50 virus replicated levels of viral genome
similar to those of the wild-type parental virus; thus, it was
unlikely that the decrease in virus yield from cultures infected
with the pp28STOP50 virus was secondary to a defect in viral
DNA replication (Fig. 2). Taken together, the results of these
experiments suggest that the deficit(s) in infectious virus pro-
duction in cells infected with the pp28STOP50 virus was likely
related to a defect(s) in virus assembly and/or virus release.
The defect in the replication of the pp28STOP50 virus is
associated with a decrease in the production of enveloped
virions. The assembly of the pp28STOP50, pp28STOP61, and
wild-type viruses was investigated utilizing several assays. Ini-
tially, the assembly of enveloped virions was studied by EM.
HF were infected with wild-type, pp28STOP61, and pp28STOP50
viruses at similar MOIs and fixed on day 5 postinfection. The
numbers of cytoplasmic capsids, tegumented capsids, and envel-
oped particles were counted in multiple frames and multiple
cells within each frame (Fig. 5A). The ratio of enveloped
particles to the total number of viral particles indicated that
about 45% of wild-type and pp28STOP61 viral cytoplasmic
FIG. 2. Virus yield and viral DNA replication of HF infected with
wild-type (WT) and pp28STOP50 viruses (MOI, 0.01). Cells and su-
pernatants from 35-mm dishes infected with the wild type and the pp28
STOP50 virus were combined, and titers were determined as described
in Materials and Methods. Viral genome copy numbers were deter-
mined by real-time PCR as previously described and reported as a log
of the copy number (24).
FIG. 3. Virus entry of wild-type (WT), pp28STOP61, and pp28STOP50 viruses in HF. Monolayers of HF on 13-mm coverslips were infected
at 4°C with wild-type, pp28STOP61, and pp28STOP50 viruses at an MOI of approximately 5. Following an incubation at 4°C for 90 min, the
cultures were shifted to 37°C for 2 h. Coverslips were fixed at 0 min and 2 h, and then the cells were assayed for expression of IE-1 antigen by using
MAb p63-27 developed with a Texas Red-conjugated anti-mouse immunoglobulin G (red). Nuclei were stained with Hoechst dye (blue).
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particles appear to have an envelope (Fig. 5B). In contrast,
using the same criteria that were used to identify enveloped
particles in the micrographs of the wild-type and pp28STOP61
virus-infected cells, we determined that 15% of particles in
cells infected with the pp28STOP50 virus were enveloped (Fig.
5B). In all cases, similar numbers of particles could be ob-
served in the nuclei of infected cells. This result suggested that
the defect in the pp28STOP50 virus was associated with a
decrease in the production of enveloped particles in the cyto-
plasm of infected cells.
These results were confirmed using a second methodology.
Virions were gradient purified from HF that had been infected
at MOIs similar to those of the pp28STOP61 and pp28STOP50
viruses. In these experiments, we used the pp28STOP61 virus
instead of the wild-type virus for several reasons, including (i)
the finding that the pp28STOP61 virus replicated to levels
similar to those of the wild-type virus, (ii) the in vitro replica-
tion phenotype of the pp28STOP61 virus was indistinguishable
from that of the wild-type virus, and (iii) the pp28STOP61
virus allowed us to study the role of aa 44 to 59 of pp28 in
virion assembly without the introduction of the additional
structural complexity of aa 62 to 190 in the wild-type virus.
Fractionation of the gradients revealed that infectious extra-
cellular virus in cells infected with either the pp28STOP61 or
the pp28STOP50 virus exhibited similar densities and that
peak infectivity could be found midway down the gradient,
within one fraction of one another (Fig. 6A). The differences in
the levels of infectivity in these fractions was approximately 1.5
logs (Table 1), a value that was within the range of differences
in viral DNA copy numbers determined for these fractions
(Fig. 6B and Table 1). Thus, in this experiment, it appeared
that the pp28STOP50 virus-infected HF produced infectious
virions that banded with similar densities following ultracen-
trifugation but that the quantity of extracellular infectious par-
ticles and viral DNA-containing particles was reduced in cells
infected with the pp28STOP50 virus compared to cells infected
with the pp28STOP61 virus (Fig. 6A and B). Consistent with
these results, total extracellular viral particles derived from HF
that had been infected with the pp28STOP61 and pp28
STOP50 viruses prior to application to the gradient had similar
differences in the levels of infectivity (1.3 logs) and viral DNA
copy numbers (l log) (Table 1). These results suggest that the
decrease in infectious virus produced by cells infected with the
pp28STOP50 virus could be explained by the production of
fewer infectious extracellular particles and was not the result of
the production of a similar number of particles but with a
decreased infectivity of the individual particles.
Somewhat different results were noted when intracellular
viruses were analyzed following purification by ultracentrifu-
gation through density gradients. The results of these experi-
ments demonstrated a greater disparity between the genera-
tion of infectious particles than in the replication of viral DNA
in HF infected with the pp28STOP50 mutant virus and the
pp28STOP61 virus (Fig. 6A and B and Table 1). This result
raised the possibility that similar numbers of DNA-containing
particles were produced in pp28STOP50 virus- and
pp28STOP61 virus-infected HF but that fewer infectious par-
ticles were assembled in pp28STOP50 virus-infected cells. To
address the possibility that pp28STOP50 virus-infected HF
failed to assemble amounts of infectious virions similar to
those of cells infected with the pp28STOP61 virus, we analyzed
the quantity of several viral proteins together with the DNA
copy number in gradient fractions from both the extracellular
and the intracellular STOP61 and STOP50 viruses. The quan-
tity of viral proteins was measured by Western blot analysis
using specific MAbs followed by densitometry (Fig. 6C). When
the DNA copy number present in particles was determined
from the fractions containing infectious virus, approximately
55% of the total (intracellular plus extracellular) DNA-con-
taining particles from pp28STOP50 virus-infected cells re-
mained intracellular, compared to only 20% of particles from
pp28STOP61 virus-infected cells (Table 1). In agreement with
previous findings, this result suggested that the pp28STOP50
virus had a defect in virus assembly/release into the extracel-
lular supernatant, unlike the pp28STOP61 virus (Table 1). The
amounts of the UL86 (MCP) present in the peak fractions of
intracellular particles from the two viruses were similar
(pp28STOP61/pp28STOP50 ratio for MCP  1.5) as were the
copy numbers of viral DNA (pp28STOP61/pp28STOP50 ratio
for DNA  1.52), suggesting that the defect in the production
of extracellular particles by pp28STOP50 virus-infected cells
could not be explained by differences in the synthesis of MCP
or the assembly of DNA-containing particles within the in-
fected cells (Table 1). However, the infectivity of pp28STOP50
intracellular particles (4.75 logs) was about 1.3 logs lower than
the infectivity of the pp28STOP61 particles (6.00 logs), indi-
cating that a significant number of MCP- and DNA-containing
intracellular particles produced in pp28STOP50 virus-infected
HF were not infectious, perhaps as a result of being nonenvel-
oped, as suggested by the EM findings (Table 1). This inter-
pretation was also consistent with the observation that intra-
cellular particles from the pp28STOP50 virus-infected cells
had a gB/MCP ratio (1.64) of about 50% of the gB/MCP ratio
of either intracellular or extracellular particles isolated from
pp28STOP61-infected HF (2.7 and 3.10, respectively), or,
more interestingly, of extracellular particles from pp28
STOP50-infected HF (3.06) (Table 1). Interestingly, similar
calculations from only one experiment in which the ratio of gM
FIG. 4. Intercellular spread of the wild type (WT) and the pp28
STOP50 virus. Monolayers of HF on 13-mm coverslips were infected
with the wild type or the pp28STOP50 virus at an MOI of 0.1 and
overlaid with agarose to prevent extracellular virus spread. The mono-
layers were fixed on days 3, 4, and 6 postinfection and then stained with
MAb p63-27 to detect IE-1 expression. The number of nuclei per
individual focus was counted. Approximately 20 foci per time point
(and virus) were counted, and the means and standard errors are
shown at the various time points.
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complex to MCP was measured revealed results that were
consistent with the results from the more extensive analysis of
gB. In these experiments, the gM/MCP ratios for intracellular
and extracellular particles from pp28STOP61 virus-infected
cells were 2.99 and 3.02, respectively, and 1.89 and 2.95 for the
intracellular and extracellular particles from pp28STOP50 vi-
rus-infected cells. These results suggest that only a fraction of
intracellular pp28STOP50 viral particles were enveloped (gB
and gM containing) and, therefore, infectious.
The deficit in the envelopment of the pp28STOP50 mutant
virus could be explained by a defect in tegumentation leading
to a defect in envelopment. This possibility was examined ini-
tially by assaying the quantities of a major tegument protein,
pp65, in both extracellular and intracellular particles. The
amount of pp65 in intracellular particles purified from the
pp28STOP50 virus-infected cells was greater than the amount
detected in intracellular or extracellular particles purified from
the pp28STOP61-infected cells (Fig. 6C and Table 1). Extra-
cellular pp28STOP50 virions had decreased amounts of pp65
compared to pp28STOP61 virions, consistent with the conclu-
sion that fewer particles were released by cells infected with
the pp28STOP50 virus (Fig. 6C and Table 1). Thus, it was
FIG. 5. EM analysis of virus-infected cells and estimation of frequency of enveloped particles in cytoplasm of infected cells. Monolayers of HF
were infected with wild-type (WT), pp28STOP61, and pp28STOP50 viruses at an MOI of 0.1 and processed for EM at 5 days postinfection.
(A) Multiple frames from each sample were imaged and photographed. Nuclear (top row) and cytoplasmic (bottom row) particles from a
representative cell are shown at final magnifications of 30,000 and 20,000, respectively. Open and filled arrows indicate nonenveloped particles
and enveloped particles, respectively. (B) The numbers of enveloped and nonenveloped particles were counted in each frame and tabulated as a
ratio of enveloped particles to total particles in the cytoplasm of infected cells (n  10). There was no significant difference between the ratios of
enveloped particles to total particles for the wild type and the pp28STOP61 mutant virus (P  0.5), whereas the pp28STOP50 virus-infected cells
contained a smaller ratio of enveloped particles to total particles than either the wild-type (P  0.001) or the pp28STOP61 (P  0.001)
virus-infected cells. Paired, one-tailed t tests were used to analyze the ratios of enveloped particles to total particles for the wild-type, pp28STOP61,
and pp28STOP50 viruses.
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unlikely that the deficit in envelopment of the pp28STOP50
mutant virus was initially secondary to a defect in tegumenta-
tion. In contrast to these findings, the pp28/MCP ratios from
pp28STOP61 intracellular and extracellular particles were sim-
ilar. However, intracellular particles from pp28STOP50 virus-
infected HF had a pp28/MCP ratio of about 50% of that of
pp28STOP50 extracellular particles, indicating that lesser
amounts of pp28Mut50 protein were present in the population
of intracellular particles (Table 1). This result also suggested
that only a fraction of intracellular particles from pp28STOP50
FIG. 6. Gradient separation and analysis of extracellular and intracellular viruses from pp28STOP61- and pp28STOP50-infected cells. (A) In-
tracellular (IC) and extracellular (EC) particles were prepared as described in Materials and Methods and fractionated on 20 to 70% sorbitol
gradients as described previously (6). The infectivity titers of gradient fractions (1 ml) collected from the bottom of density gradients were
determined as described in Materials and Methods. (B) Real-time PCR of viral genome copy numbers in fractions from gradients. Fifty microliters
of each fraction was extracted using column technology (QIAGEN blood PCR kit; QIAGEN, Valencia, CA) and assayed by real-time PCR as
described in Materials and Methods. Results are expressed as genome copy number per fraction. (C) Relative expression of MCP, gB, pp28, and
pp65 in each fraction as detected by Western blotting with specific MAbs. Fifty microliters of each fraction was loaded on 12% polyacrylamide gels
and subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis and Western blotting as described in Materials and Methods. Following
development with enhanced chemiluminescence, densitometry was carried out and the relative signal for each lane was determined. Note that
densitometry was done only with fluorograms acquired during the same experiment and developed for the same time interval. The fluorograms
shown for pp28 and pp65 were processed in Adobe Photoshop to remove nonspecific background signals assumed to be secondary to nonspecific
binding of primary antibodies; however, densitometry was performed prior to image processing to remove background. The pp65- and pp28-specific
bands were not processed. *, gradient fraction with peak infectivity.
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virus-infected HF contained the mutant form of pp28 and,
therefore, were enveloped during assembly. Alternatively, the
possibilities that only a threshold amount of pp28 was required
for the assembly of an enveloped particle and that each
particle derived from pp28STOP50-infected cells contained
a decreased amount of the pp28 mutant could not be ruled
out. Consistent with the latter possibility was the finding that
extracellular particles from pp28STOP50 virus-infected
cells had a pp28/MCP ratio that was less than that of
pp28STOP61 extracellular particles, arguing the possibility
that only a threshold amount of pp28 was required for the
successful envelopment of an infectious particle and that
each particle contained limiting amounts of the pp28 mutant
protein (Table 1).
The pp28 mutant protein encoded by the pp28STOP50 virus
fails to concentrate in the AC. The pp28 protein is localized
and increases in amount in the AC late in infection (22). To
investigate the possibility that the deficit in the production of
infectious virus by the pp28STOP50 virus-infected HF was
secondary to the altered localization of the pp28STOP50 mu-
tant to the AC or a lack of the accumulation of pp28 in the AC,
we analyzed the kinetics of pp28 localization to the AC by
FRAP experiments. An EGFP-tagged pp28 protein was ex-
pressed in HF following electroporation of a plasmid encoding
the first 35 aa, 50 aa, or 61 aa of pp28 or the full length of the
pp28 molecule, each of which was fused at its C terminus to
EGFP (pp28Mut35-EGFP, pp28Mut50-EGFP, pp28Mut61-
EGFP, or pp28WT-EGFP). HF were electroporated with the
indicated plasmid and then infected with HCMV 48 h later at
an MOI of 0.1. A FRAP assay of live infected HF was carried
out 6 days postinfection. The fluorescence of pp28Mut35-
EGFP, pp28Mut50-EGFP, pp28Mut61-EGFP, or pp28WT-
EGFP in the prebleaching compartment was saturated late in
infection (Fig. 7A). We selectively bleached the entire AC and
monitored the fluorescence recovery in this region (Fig. 7A).
The fluorescence in the bleached region dropped to about 20%
immediately after bleaching. Thus, for these FRAP experi-
ments, the fluorescence in the bleached region was normalized
to 20% at time zero postbleaching, and the recovered fluores-
cence was monitored for 20 min postbleaching. For pp28WT-
EGPF, the fluorescence in the bleached AC recovered to 32%
(Fig. 7A). Similar values were noted for both the pp28Mut50-
EGFP and pp28Mut61-EGFP proteins (45% and 41%, respec-
tively) (Fig. 7A). These values indicated that the transport of
these pp28 mutants was similar to that of the wild type and that
differences between the rates of localization of pp28Mut50 and
wild-type pp28 (and pp28Mut61) to the AC could not explain
the defect observed in the replication of the pp28Mut50-ex-
pressing recombinant virus (pp28STOP50). In contrast to
these findings, the recovery of the pp28Mut35 protein in the
AC reached only 25% (5% above postbleaching levels) and
then appeared to decline, suggesting that the AC was less
efficiently refilled by this mutant form of pp28 than was the
wild type, pp28Mut61, or pp28Mut50 (Fig. 7A). This finding
was consistent with our previous results using static imaging
(24).
In the next series of experiments, the accumulation of pp28,
pp28Mut61, pp28Mut50, and pp28Mut35 in the AC was as-
sayed using transfected/infected cells and FRAP as described
above. In these experiments, the entire cytoplasm (except the
AC and nucleus) was bleached, and the recovery of the fluo-
rescence signal in a region of cytoplasm surrounding the AC
was measured over time (Fig. 7B). The fluorescence in the
measured region was normalized to 20% at time zero post-
bleaching. We noted significant differences in the recovery
rates. The fluorescence signal in wild-type pp28-EGFP-trans-
fected, HCMV-infected cells recovered to about 23% follow-
ing photobleaching of the cytoplasm (Fig. 7B). Similarly, the
recovery of the fluorescence signal from the pp28Mut61-trans-
fected, HCMV-infected cells was 24% during the measure-
ment interval (Fig. 7B). The analysis of the pp28Mut35 protein
suggested similarly inefficient refilling of this area of the cell,
presumably because there was a minimal amount of the
pp28Mut35 protein in the AC available to refill the cytoplasm
of these previously bleached cells (Fig. 7B). In contrast to these
findings, the recovery of fluorescence in the photobleached
cytoplasm of pp28Mut50-transfected, HCMV-infected cells
was almost 40%, indicating that the trafficking of pp28Mut50
out of the AC was significantly increased compared to that of
either the pp28Mut61 mutant or the wild-type pp28 (Fig. 7B).
When the rate of movement of these proteins into and out of
the AC is expressed as a ratio of recovery of fluorescence at 20
min following photobleaching to a value of 20% at time zero,
these differences are more apparent. The ratios of movement
TABLE 1. Estimations of the levels of viral proteins, viral DNA, and infectivity in extracellular and intracellular virion particles produced in
cells infected with the pp28STOP61 or pp28STOP50 viruses
Virus and
domaina MCP
b gB pp28 pp65 gB/MCPratioc
pp28/MCP
ratioc
pp65/MCP
ratioc
DNA copy
numberd
Infectivity
leveld
pp28STOP61
IC (6) 4.67 12.75 7.56 10.27 2.7 (0.05) 1.6 (0.02) 2.2 (0.10) 1.7 109 (9.22) 6.00
EC (5) 9.74 27.96 14.40 20.36 3.1 (0.10) 1.58 (0.08) 2.14 (0.14) 6.9 109 (9.84) 8.47
pp28STOP50
IC (7) 3.13 5.00 1.95 22.10 1.64 (0.07) 0.65 (0.06) 6.92 (0.23) 1.1 109 (9.04) 4.75
EC (6) 3.56 10.59 3.74 7.23 3.06 (0.07) 1.04 (0.01) 1.93 (0.05) 8.9 108 (8.95) 6.91
a The numbers in parentheses represent fractions containing peak infectivity. IC, intracellular; EC, extracellular.
b The densities of the corresponding proteins in peak fractions from Fig. 6C are shown.
c The ratios of envelope (gB), tegument (pp28), and tegument (pp65) proteins to MCP were calculated for the peak fractions of infectivity. Values represent the
means (standard errors) of the results of three to four independent experiments. Results of a single representative experiment are shown in Fig. 6C.
d The viral DNA copy numbers in parentheses and infectivity levels are represented in log scale for the peak fractions of infectivity. Note that prior to application
to the gradients, the total numbers of extracellular viral particles from HF (as analyzed in clarified supernatant) that had been infected with the pp28STOP61 and pp28
STOP50 viruses differed by comparable levels of infectivity (1.3 logs) and viral DNA copy number (l log).
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into the AC to movement out of the AC for wild-type pp28 and
pp28Mut61 were 1.5 and 1.7, respectively, indicating that, at
steady-state kinetics, the localization of these proteins in the
AC was favored (Table 2). In contrast, the ratio of movement
into the AC to movement out of the AC for pp28Mut50 was
1.1, indicating that, at late times following infection, nearly
equivalent amounts of pp28Mut50 were exiting the AC as were
trafficking into this compartment in HF (Table 2). Moreover,
the recovery pattern on the plot showed that, in contrast to
the wild type and pp28Mut61, the recovered fluorescence of
pp28Mut50 in the cytoplasm was not saturated during the
measured time (Fig. 7B). When the same ratios were calcu-
lated for the pp28Mut35 protein, the ratio of movement into
the AC to movement out of the AC was 0.9, confirming our
findings with static imaging carried out at equilibrium that the
majority of the pp28Mut35 protein is localized outside of the
AC (Table 2). Taken together, these results were consistent
with the favored kinetics for the trafficking of the pp28Mut50
out of the AC and suggested that the failure of this mutant
form of pp28 to accumulate in the AC could limit its concen-
FIG. 7. FRAP analysis of accumulation of pp28 wild type, pp28Mut61, pp28Mut50, and pp28Mut35-EGFP in the AC. HF were transfected with
pp28WT-EGFP, pp28Mut61-EGFP, pp28Mut50-EGFP, or pp28Mut35-EGFP, followed by infection with HCMV at an MOI of 0.1 48 h later. At
day 6 postinfection, the infected live HF were subjected to FRAP analysis as described in Materials and Methods. Illustrations at the tops of the
images show the areas of FRAP, a cell prior to bleaching (left), a region selectively bleached (middle, black portion), and a measured recovery
region over time (right, green-hatched portion). (A) Localization of pp28WT-EGFP, pp28Mut61-EGFP, pp28Mut50-EGFP, and pp28Mut35-
EGFP to the AC. FRAP was performed using the entire AC of infected cells (n  5). At time zero postbleaching, the fluorescence in the bleached
region was normalized to 20% of the prebleaching fluorescence. Fluorescence recovery was monitored, and results were plotted over time.
(B) Movement of pp28WT-EGFP, pp28Mut61-EGFP, pp28Mut50-EGFP, and pp28Mut35-EGFP out of the AC. FRAP analysis was performed
with the cytoplasm of infected cells (n 3). Fluorescence recovery was monitored, and the results were plotted over time as described above. Error
bars represent standard errors of the means.
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tration in the AC and, therefore, its role in the envelopment of
the virion.
DISCUSSION
Although pp28 has been shown to be an essential tegument
protein for the assembly of an infectious HCMV particle, its
precise role in assembly has not been elucidated. Cells infected
with recombinant viruses in which pp28 was deleted failed to
produce enveloped particles, and the analysis of cells infected
with this mutant virus complemented with a retrovirus express-
ing pp28 suggested that pp28 has a role in the envelopment of
the particle (26). However, it was unclear whether the deletion
of pp28 resulted in a loss of tegument and/or envelope assem-
bly, and because progeny virions were not produced, the pro-
tein composition of particles produced by this recombinant
virus also could not be analyzed. Although the stage at which
virion assembly was blocked was not determined, this report
convincingly demonstrated that pp28 has a critical role in the
cytoplasmic envelopment of HCMV (26). Similarly, our results
also suggested that the replication-impaired phenotype of the
pp28 mutant virus, pp28STOP50, resulted from a defect in the
assembly of enveloped particles. Analysis of this mutant virus
was particularly informative because, although it exhibited a
replication-impaired phenotype, it produced sufficient amounts of
both intracellular and extracellular virus for the characteriza-
tion of its assembly, including the protein composition of the
particle. The results of these studies indicated that the pp28
STOP50 virus was replication impaired secondary to a defect
in assembly based on findings that (i) the viral genome was
replicated to levels similar to those of replication-competent
wild-type viruses; (ii) intracellular particles produced by the
pp28STOP50 mutant contained amounts of MCP and viral
DNA similar to the amounts in particles purified from the
replication-competent pp28STOP61 virus; (iii) the infectivity
of intracellular particles produced in pp28STOP50-infected
cells was about 1.5-log lower than that of particles from
pp28STOP61-infected cells, suggesting that the defect in the
pp28STOP50 virus was not secondary to a block in the release
of infectious virus; and (iv) extracellular virions produced by
cells infected with the pp28STOP50 mutant could readily enter
permissive HF. Taken together with previous findings that
demonstrated that pp28 was expressed late in the replicative
cycle of HCMV, these studies were consistent with earlier
results that proposed a key role of pp28 in the cytoplasmic
assembly of infectious HCMV (5, 15, 26).
The pp28STOP50 mutant virus expressed only 7 acidic aa of
the 16-aa acidic cluster present in the 18 aa between aa 44 and
61 of the pp28STOP61 viral mutant, including the sequence
GEDDD that is duplicated within this 16-aa sequence. How-
ever, the production of infectious virus was impaired in the
pp28STOP50 virus mutant compared to that in the pp28STOP61
virus, indicating that the remaining stretch of acidic amino
acids between aa 44 and 50 in the pp28STOP50 mutant virus
was insufficient to support wild-type virus assembly. Previously,
we have shown that a recombinant virus encoding a pp28
mutant protein constructed by the deletion and transplantation
of the 16-aa acidic cluster (aa 44 to 59) to the carboxyl termi-
nus of pp28 was replication incompetent (24). The finding of
context dependence for the function of the acidic cluster
present between aa 44 and 59 in virus raised the possibility that
the acidic domain of pp28 could have functions other than
simply acting as an intracellular trafficking motif that directed
pp28 to a specific cellular compartment. This function was
previously proposed for this stretch of acidic amino acids in
pp28 based on the findings from an analysis of an acidic cluster
in the amino-terminal domain of HSV homolog UL11 (16).
Clusters of amino acids in the cytoplasmic domains of viral
glycoproteins and also present in UL11 have been reported to
function in intracellular trafficking through interactions with
cellular adaptor proteins such as PACS-1 (3, 20, 29, 31). Con-
siderable variability in the sequences of amino acids found in a
number of acidic clusters has been described, and in many
cases, phosphorylation of adjacent amino acids has been shown
to regulate interactions with PACS-1 (3). In some cases, acidic
clusters of 6 to 7 aa have been reported to be sufficient for
interaction with cellular adaptor proteins, and bipartite acidic
clusters have been described (3, 31). Thus, we expected that
the remaining seven acidic amino acids on the carboxyl termi-
nus of pp28STOP50 should have been sufficient to interact
with cellular adaptors such as PACS-1 and to support levels
of replication that were similar to those of the wild-type virus.
Yet the results in the current study argued that an intact
acidic cluster (16 aa) within the carboxyl terminus of the
pp28STOP61 mutant virus was required for levels of wild-type
virus replication. A study of the proprotein convertase PC6B
described two acidic clusters in the cytoplasmic domain of this
protein that functioned differently in intracellular sorting (31).
The carboxyl-terminal acidic cluster of this protein interacted
with PACS-1 but was not required for the intracellular local-
ization of the protein (31). The authors of this study postulated
that the interactions of PC6B with PACS-1 contributed to the
intracellular localization of PC6B by directing the protein to
the TGN, a step required for efficient PC6B localization that
was shown to be absolutely dependent on the acidic cluster of
amino acids more proximal to the amino terminus of the pro-
tein (31). Additional mutations in the remaining amino acids in
pp28STOP50 could determine whether the contiguous se-
quence of acidic amino acids between aa 44 and 59 of pp28
functions as a bipartite sorting sequence similar to the acidic
amino acids in PC6B. In addition, additional mutations in the
remaining acidic amino acids at positions 44 to 50 could iden-
tify the essential amino acids required for wild-type replication
TABLE 2. Recovery kinetics of the pp28 and pp28Mut proteins
in FRAP assays
Rate type
Ratio of fluorescence recoverya
pp28WT pp28Mut61 pp28Mut50 pp28Mut35
Recovery in AC 1.6 2.0 2.2 1.4
Recovery in cytoplasm 1.1 1.2 2.0 1.5
Accumulation in AC 1.5 1.7 1.1 0.9
a Ratios of fluorescence recovery are based on the ratio of fluorescence at 20
min to the fluorescence at 0 min. For the kinetics of accumulation in AC, i.e.,
localization in the AC, the ratio of fluorescence recovery in the AC to the
fluorescence recovery in the cytoplasm was calculated. Note that the accumula-
tion rate of pp28Mut35 in AC was 1.0, indicating that, at equilibrium, the
majority was localized outside of the AC, whereas pp28WT had an accumulation
rate of 1.5.
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and perhaps provide clues to the role of this domain in pp28 in
virus assembly.
Characterization of the assembly of infectious virions pro-
vided evidence consistent with a defect in the envelopment of
the pp28STOP50 recombinant virus compared to that in both
the wild-type virus and the pp28STOP61 mutant virus. Several
findings led to this conclusion. First, EM indicated that only
about 15% of intracellular particles in pp28STOP50 virus-
infected cells were enveloped compared to over 40% of parti-
cles in pp28STOP61 virus-infected cells. Analysis of the ge-
nome copy number and protein composition of intracellular
particles purified from pp28STOP50 virus- and pp28STOP61
virus-infected cells indicated that both viruses produced a pop-
ulation of particles that contained similar quantities of viral
DNA and MCP. Furthermore, analysis of the intracellular
particles for the tegument protein pp65 (UL83) also revealed
similar amounts of this protein in intracellular particles iso-
lated from cells infected with the two mutant viruses. In fact,
intracellular particles from pp28STOP50 virus-infected cells
appeared to have a greater amount of pp65 than particles from
pp28STOP61 virus-infected cells, suggesting that a decrease in
the acquisition of the pp28 tegument protein resulted in an
accumulation of pp65 on intracellular particles, perhaps sec-
ondary to a block and/or a delay in the normal assembly path-
way. Taken together, these findings suggested that the defect in
the pp28STOP50 mutant virus was not associated with a gen-
eralized defect in the production of DNA-containing particles
or capsids or in the tegumentation of cytoplasmic particles but
rather with a defect in a late step of assembly, such as envel-
opment, of the infectious particle. A formal particle count was
not carried out, but under identical conditions of gradient
purification, similar viral DNA copy numbers and amounts of
MCP were detected in the peak gradient fractions for both
viruses, thus arguing that cells infected with either virus pro-
duced similar numbers of capsid-containing particles and that
these particles also contained similar amounts of viral DNA.
However, the intracellular particles purified from cells infected
by these viruses differed significantly in level of infectivity.
Cells infected with the pp28STOP61 virus produced approxi-
mately 1.3 log more infectious intracellular particles than cells
infected with the pp28STOP50 mutant virus, a finding consis-
tent with the results from EM that suggested that only about
15% of intracellular particles in cells infected with the pp28
STOP50 mutant virus were enveloped. In addition, intracellu-
lar particles purified from pp28STOP50 virus-infected cells
contained lesser amounts of the envelope gB (and gM) relative
to the MCP than intracellular particles purified from
pp28STOP61 virus-infected cells. Interestingly, the ratios of gB
and gM to MCP were similar for both intracellular and extra-
cellular particles from pp28STOP61 virus-infected cells and
from extracellular particles isolated from the supernatant of
pp28STOP50 virus-infected cells, suggesting that a relatively
fixed stoichiometry of gB (gM) and MCP in particles was
associated with the infectivity of HCMV virions. The lower
gB/MCP (and gM/MCP) ratios in intracellular particles iso-
lated from pp28STOP50 virus-infected cells suggested either
that all particles in this population contained decreased
amounts of gB (gM) or, more likely, that only a minor popu-
lation of particles contained gB (gM) in amounts similar to
those in particles from pp28STOP61 virus-infected cells and
that the remaining particles were not completely enveloped.
Thus, these findings were consistent with the production of
nearly equivalent numbers of intracellular particles by cells
infected with the pp28STOP50 virus and cells infected with the
pp28STOP61 virus but a decrease in the production of infec-
tious intracellular particles as well as a decrease in the number
of infectious particles released into the extracellular superna-
tant. When the percentages of total infectious particles present
intracellularly are compared for these two viruses, this defect
was also apparent. Of the total amount of infectious virus
produced late in infection, approximately 55% of that pro-
duced by cells infected with the pp28STOP50 virus remained
inside the cells, whereas less than 20% of infectious virus
produced by the pp28STOP61 virus was present in the cell.
Taken together, our findings were most consistent with a de-
fect in the envelopment of the pp28STOP50 virus and also
raised the possibility that during infection in HF, HCMV en-
velopment and virus release into the supernatant could be
linked, i.e., defects in envelopment appeared to reduce the
efficiency of virus release from the cell.
Interestingly, the defect that resulted in the impaired repli-
cation of the pp28STOP50 virus did not result in a complete
block in the production of infectious virus, suggesting that a
fraction of particles contained adequate amounts of the
pp28Mut50 mutant protein to support the envelopment and
release of infectious particles into the extracellular media. As
noted above, this conclusion was supported by the finding that
infectious particles isolated from the extracellular supernatant
contained a gB/MCP ratio similar to that of extracellular virus
isolated from the supernatant from cells infected with the
pp28STOP61 mutant virus. However, the number of particles
released from cells infected with the pp28STOP50 virus was
reduced significantly based on the viral DNA content and the
MCP content of extracellular particles from the gradient frac-
tion containing the peak infectivity. Although we cannot de-
termine the specific infectivity and protein content of individ-
ual particles within this fraction, our results are compatible
with a mechanism in which the majority of intracellular parti-
cles produced in cells infected with the pp28STOP50 virus
mutant fail to become enveloped and are not released from the
infected cell. The minority of particles that become enveloped
appear to acquire similar amounts of gB. Thus, it appeared
that the defect in the assembly of the pp28STOP50 mutant
virus was related to the decreased efficiency of envelopment,
presumably secondary to a loss in function of the pp28Mut50
mutant protein.
The loss in function of the pp28Mut50 protein that led to
decreased envelopment of intracellular particles remains un-
defined. A failure to localize to the AC was a possibility, based
on our previous studies that demonstrated a failure of pp28
mutants expressing only aa 1 to 44 to localize in the AC (24).
In cells infected with the recombinant pp28STOP50 virus,
static imaging revealed that the pp28Mut50 protein localized
to the AC, but less efficiently than either the pp28Mut61 pro-
tein or the wild-type pp28 (24). These results were confirmed
in the current study utilizing FRAP to analyze protein traffick-
ing in living cells. These studies indicated that the pp28Mut50
protein localized to the AC as efficiently as either the
pp28Mut61 or wild-type pp28 protein; however, the pp28
Mut50 protein exited the AC more than twice as rapidly as
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either the pp28Mut61 or wild-type pp28 protein. This finding
indicated that, at steady state, only a fraction of the pp28Mut50
protein localized in the AC compared to the amount of either
the pp28Mut61 or the wild-type pp28 protein, a finding con-
sistent with previous results using static imaging (24). The
decreased amount of the pp28Mut50 in the AC could in turn
limit the envelopment and assembly of infectious virus, partic-
ularly if the pp28 concentration in the AC was rate limiting in
the assembly of infectious particles.
Although our findings provided an explanation of the de-
creased production of infectious virions from pp28STOP50
mutant virus-infected cells based on decreased amounts of the
pp28Mut50 mutant protein in the AC, it was unclear why the
pp28Mut50 mutant protein failed to accumulate in the AC.
The results from studies using FRAP indicated that the mutant
protein was efficiently localized to the AC; thus, it is unlikely
that the interaction with adaptor proteins required for cellular
trafficking in the secretory pathway was altered by this muta-
tion. An obvious possibility was that the pp28Mut50 protein
could not interact efficiently with cellular and/or viral proteins
within the AC and thus exited the AC nearly as rapidly as it
entered this compartment. Because this mutant was not com-
pletely defective in assembly, it was also likely that once a
sufficient quantity of the pp28Mut50 mutant protein accumu-
lated in the AC, the assembly of an infectious particle could
take place. Thus, it could be argued that a threshold amount of
pp28 must be present in the AC to permit envelopment and
assembly. The requirement for a threshold amount of
pp28Mut50 mutant protein in the AC for virion assembly could
be secondary to productive interactions with other viral pro-
teins, including multimerization with itself, or interactions with
cellular proteins. A corollary of such a mechanism would be
that the defect in the assembly of the pp28STOP50 virus could
be overcome by delivering more mutant protein to the AC.
Indeed, this appears to be the case in that monolayers infected
with a high MOI of the pp28STOP50 mutant virus produce
infectious virus nearly as efficiently as do monolayers infected
with the wild-type virus.
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